Skip to main content
. Author manuscript; available in PMC: 2016 Dec 15.
Published in final edited form as: Circulation. 2015 Nov 16;132(24):2305–2315. doi: 10.1161/CIRCULATIONAHA.115.017341

Figure 1.

Figure 1

The association between coffee consumption and risk of mortality in the overall population and among never smokers pooled across the three cohorts. 1a. Total coffee consumption and risk of mortality 1b. Caffeinated coffee consumption and risk of mortality 1c. Decaffeinated coffee consumption and risk of mortality. Multivariate-adjusted models adjusted for age, baseline disease status (hypertension, hypercholesterolemia, diabetes), BMI (< 20.9, 21-22.9, 23-24.9, 25-29.9, 30-34.9, ≥ 35 kg/m2), physical activity (< 3, 3-8.9, 9-17.9, 18-26.9, ≥ 27 MET-h/wk), smoking status (never, former (1 - 4 cigarettes/d), former (5 - 14 cigarettes/d), former (15 - 24 cigarettes/d), former (25 - 34 cigarettes/d), former (35 - 44 cigarettes/d), former (≥ 45 cigarettes/d), former (unknown cigarettes/d), current (1 - 4 cigarettes/d), current (5 - 14 cigarettes/d), current (15 - 24 cigarettes/d), current (25 - 34 cigarettes/d), current (35 - 44 cigarettes/d), current (≥ 45 cigarettes/d), current (unknown cigarettes/d)), overall dietary pattern (AHEI score, in quintiles), total energy intake (quintiles), sugar-sweetened beverages consumption (quintiles) and alcohol consumption (0, 0-5, 5-10, 10-15, ≥ 15 g/d). We additionally adjusted for menopausal status (yes vs. no), and postmenopausal hormone use (yes vs. no) for women. Caffeinated and decaffeinated coffee adjusted for each other.